Clinical Trial Update: The Efficacy and Safety of Metoprolol as add-on Treatment to Standard of Care in Preventing Cardiomyopathy in Patients With DMD [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating metoprolol as add-on therapy to standard of care for preventing cardiomyopathy in Duchenne muscular dystrophy patients; recruitment ong…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• METOPROLOL (METOPROLOL TARTRATE)

Snippet

Sponsor: Medical University of Gdansk | Conditions: Muscular Dystrophy, Duchenne | Phase 3 | Status: RECRUITING